CMO/CDMOs: How Technologies Are Changing Outsourcing Strategies, Services Offered, and Risks Taken

BPI Staff

September 12, 2014

1 Min Read

This podcast features:
Moderator: Susan Dexter, principal consultant at Latham Biopharm Group


Economic Trends: Rob Silber, director of supply chain/business contracts at Boehringer Ingelheim

Technology Advancements: Andrew Sandford, vice president of business development at Catalent Pharma Solutions

Facility Designs: Bill Reed, PhD, senior vice president of operations at Kalon Biotherapeutics

Service Offerings: Mark Bamforth, president and chief executive officer at Gallus BioPharmaceuticals

This podcast was recorded at the 2014 BioProcess Theater which took place at the 2014 BIO International Convention, June 23-26, 2014. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting the development and manufacture of biotherapeutics.

The 2014 BioProcess Theater consisted of five main presentation tracks: Antibody-Drug Conjugates, Single-Use Processing, Upstream Processing, Manufacturing, and Cell Therapies.

If you would like more information on these presentations, please email us: [email protected]

You May Also Like